"We have taken biopharmaceuticals from early concept studies all the way to market approval."

Dr Roger Lias

President, Eden Biodesign, Inc. & Group Commercial Director

roger.lias@edenbiodesign.com

Roger’s responsibilities include identifying and establishing strategic business partnerships and expanding Eden Biodesign's offer to the large North American biopharmaceutical sector. In addition, Roger is responsible for Global Business Development and managing Eden’s continued strong growth in Europe and Asian markets.

Roger has extensive experience in the biotechnology industry with a specific emphasis on biomanufacturing services. Prior to joining Eden, Roger held the position of Vice President, Sales and Business Development at Cytovance Biologics. At KBI BioPharma, a start-up contract biomanufacturing company, he played an active role in securing funding, building revenues and was responsible for identifying and establishing strategic business partnerships and new business relationships. Prior to this, he was Vice President, Business Development at Diosynth where he had global responsibility and headed North American sales and marketing for Lonza Biologics. In both cases Roger was instrumental in generating substantial revenue growth.